(Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | -1.3M | 2.95M | 416.47K |
Net income from continuing operations | --262.3K | ---9.21M | ---11.1M |
Operating gains losses | --389.85K | --6.97K | ---100.7K |
Depreciation and amortization | --26.85K | --1.21M | --300.6K |
Other non cash items | ---149.95K | --453.11K | --320.43K |
Change In working capital | ---1.7M | --308.45K | --986.26K |
-Change in receivables | ---1.2M | --2.89M | --329.45K |
-Change in inventory | --146.94K | --552.16K | --115K |
-Change in prepaid assets | --4.53K | --642.7K | ---- |
-Change in payables and accrued expense | ---658.93K | ---3.73M | --294.86K |
-Change in other working capital | --9.25K | ---41.82K | ---2.06K |
Cash from discontinued investing activities | |||
Operating cash flow | ---1.3M | --2.95M | --416.47K |
Investing cash flow | |||
Cash flow from continuing investing activities | 0 | 0 | |
Net PPE purchase and sale | ---- | --0 | --0 |
Net intangibles purchase and sale | ---- | --0 | --0 |
Cash from discontinued investing activities | |||
Investing cash flow | --0 | --0 | --0 |
Financing cash flow | |||
Cash flow from continuing financing activities | 57.99K | -2.05M | -512.5K |
Net issuance payments of debt | ---12.5K | ---2.05M | ---512.5K |
Net other financing activities | --70.49K | ---- | ---- |
Cash from discontinued financing activities | |||
Financing cash flow | --57.99K | ---2.05M | ---512.5K |
Net cash flow | |||
Beginning cash position | --1.32M | --595.92K | --1.49M |
Current changes in cash | ---1.24M | --896.35K | ---96.04K |
Effect of exchange rate changes | --334.49K | ---167.75K | ---68.76K |
End cash Position | --414.93K | --1.32M | --1.32M |
Free cash flow | ---1.3M | --2.95M | --416.47K |
Currency Unit | USD | USD | USD |
Audit Opinions | -- | Unqualified Opinion | -- |
No Data
No Data